- In April 2024, Colgate-Palmolive Company announced the launch of its next-generation Colgate Total Advanced Fresh Gel in North America and Europe. This product is designed specifically to combat halitosis by targeting the volatile sulfur compounds (VSCs) responsible for bad breath. Featuring dual-zinc plus arginine technology, the new formulation provides long-lasting breath protection while promoting gum health. This launch reinforces Colgate’s commitment to innovation in the oral care segment and expands its presence in the global halitosis treatment market
- In March 2024, Rowpar Pharmaceuticals Inc., the maker of TheraBreath, introduced a new line of probiotic oral rinses formulated to support healthy oral flora and reduce the recurrence of halitosis. These products are aimed at consumers seeking holistic and preventive care solutions. This move aligns with the growing consumer preference for natural, microbiome-friendly formulations and enhances Rowpar’s product portfolio in the premium halitosis treatment category
- In February 2024, Reckitt Benckiser Group PLC expanded its Listerine Smart Rinse portfolio in the Asia-Pacific region, integrating advanced enzymatic neutralizers and anti-microbial agents targeted at individuals with chronic halitosis. The expansion leverages increasing demand for specialized oral care products in emerging markets, particularly India and Southeast Asia, and highlights Reckitt's strategy to localize product innovation based on regional oral health needs
- In January 2024, F. Hoffmann-La Roche Ltd. launched a pilot program in collaboration with dental clinics across Germany to integrate its Halimeter X500 device into routine oral check-ups. The device offers real-time analysis of VSC levels, enabling accurate halitosis diagnosis and customized treatment plans. This initiative is expected to significantly advance diagnostic capabilities in the clinical halitosis segment and promote Roche's position as a diagnostic leader
- In December 2023, Abbott introduced a novel enzymatic rinse under its Sensodent brand line, combining antacids and antibacterial compounds to target halitosis originating from gastrointestinal issues. The product is tailored for patients whose bad breath stems from acid reflux and other digestive conditions. With this launch, Abbott addresses the growing need for cross-disciplinary treatments that bridge gastroenterology and dental health
